Page last updated: 2024-12-05

n-butyronitrile

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID8008
CHEBI ID51937
MeSH IDM0101908

Synonyms (53)

Synonym
n-butyronitrile
butyronitrile ,
butanenitrile
nsc-8412
butyrylonitrile
nsc8412
109-74-0
wln: nc3
propyl cyanide
1-cyanopropane
butane nitrile
n-butanenitrile
butyric acid nitrile
un2411
propylkyanid [czech]
hsdb 5013
ai3-08778
nsc 8412
brn 1361452
n-propyl cyanide
einecs 203-700-6
inchi=1/c4h7n/c1-2-3-4-5/h2-3h2,1h
butyronitrile, >=99%
n-butanitrile
CHEBI:51937
B0768
AKOS000200378
A802081
o3v36v0w0m ,
4-02-00-00806 (beilstein handbook reference)
butyronitrile [un2411] [flammable liquid]
ec 203-700-6
unii-o3v36v0w0m
propylkyanid
STL168041
butanenitrile [hsdb]
butyronitrile [mi]
n-prcn
butyronitril
butyronitile
n-c3h7cn
un 2411
DTXSID1026823
mfcd00001968
J-519976
J-002323
butyronitrile, 98%
F0001-0203
butyronitrile, analytical standard
butyronitrile, purum, >=99.0% (gc)
Q420835
EN300-27284
Z238878246
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
aliphatic nitrileAny nitrile derived from an aliphatic compound.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (14)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (14.29)18.7374
1990's3 (21.43)18.2507
2000's6 (42.86)29.6817
2010's2 (14.29)24.3611
2020's1 (7.14)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 23.59

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index23.59 (24.57)
Research Supply Index2.71 (2.92)
Research Growth Index4.65 (4.65)
Search Engine Demand Index23.28 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (23.59)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other14 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]